HLS Therapeutics Inc News

Strategic Divestiture and Financial Flexibility: HLS Therapeutics Inc's Optimistic Buy Rating

TipRanksJul 3 08:40 ET

Stifel Nicolaus Keeps Their Hold Rating on HLS Therapeutics Inc (HLS)

TipRanksJul 3 07:52 ET

HLS Therapeutics Downgraded to Hold at Stifel GMP on Revenue Concerns; Price Target Cut to C$5.00

MT NewswiresNov 10, 2023 09:47 ET

HLS Therapeutics Inc (HLS) Receives a Buy From Stifel Nicolaus

TipRanksNov 7, 2023 09:10 ET

Bloom Burton Remains a Buy on HLS Therapeutics Inc (HLS)

TipRanksAug 13, 2023 06:20 ET

Clarus Sticks to Its Buy Rating for HLS Therapeutics Inc (HLS)

TipRanksAug 11, 2023 10:20 ET

HLS Therapeutics Inc (HLS) Gets a Buy Rating From Stifel Nicolaus

TipRanksAug 10, 2023 16:30 ET

Stifel Nicolaus Remains a Buy on HLS Therapeutics Inc (HLS)

TipRanksJul 10, 2023 17:10 ET

Stifel Nicolaus Keeps Their Buy Rating on HLS Therapeutics Inc (HLS)

TipRanksJun 22, 2023 10:30 ET

Stifel Nicolaus Keeps Their Buy Rating on HLS Therapeutics Inc (HLS)

TipRanksJun 12, 2023 10:30 ET

HLS Therapeutics Inc (HLS) Receives a Buy From Clarus

TipRanksMay 12, 2023 08:50 ET

HLS Therapeutics Inc (HLS) Receives a Buy From Stifel Nicolaus

TipRanksMay 11, 2023 11:41 ET